Mcintyre Freedman & Flynn Investment Advisers Inc Abbott Laboratories Call Options Transaction History
Mcintyre Freedman & Flynn Investment Advisers Inc
- $138 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ABT
# of Institutions
3,132Shares Held
1.29BCall Options Held
8.43MPut Options Held
8.71M-
Vanguard Group Inc Valley Forge, PA165MShares$17 Billion0.38% of portfolio
-
Black Rock Inc. New York, NY133MShares$13.7 Billion0.36% of portfolio
-
Capital Research Global Investors Los Angeles, CA84MShares$8.65 Billion2.23% of portfolio
-
State Street Corp Boston, MA74.7MShares$7.7 Billion0.39% of portfolio
-
Capital International Investors Los Angeles, CA70.2MShares$7.23 Billion1.65% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $180B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...